Logo image of ALTM

Arcadium Lithium plc (ALTM) Stock Fundamental Analysis

NYSE:ALTM - New York Stock Exchange, Inc. - JE00BM9HZ112 - Common Stock - Currency: USD

5.84  0 (0%)

After market: 5.84 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALTM. ALTM was compared to 85 industry peers in the Chemicals industry. There are concerns on the financial health of ALTM while its profitability can be described as average. ALTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALTM had positive earnings in the past year.
ALTM had a negative operating cash flow in the past year.
ALTM had positive earnings in 4 of the past 5 years.
ALTM had a positive operating cash flow in 4 of the past 5 years.
ALTM Yearly Net Income VS EBIT VS OCF VS FCFALTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

ALTM's Return On Assets of 1.01% is in line compared to the rest of the industry. ALTM outperforms 47.06% of its industry peers.
The Return On Equity of ALTM (1.65%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.86%, ALTM is not doing good in the industry: 63.53% of the companies in the same industry are doing better.
ALTM had an Average Return On Invested Capital over the past 3 years of 8.50%. This is in line with the industry average of 6.84%.
The 3 year average ROIC (8.50%) for ALTM is well above the current ROIC(2.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.01%
ROE 1.65%
ROIC 2.86%
ROA(3y)8.14%
ROA(5y)4.55%
ROE(3y)13.03%
ROE(5y)7.26%
ROIC(3y)8.5%
ROIC(5y)N/A
ALTM Yearly ROA, ROE, ROICALTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

ALTM's Profit Margin of 10.24% is amongst the best of the industry. ALTM outperforms 88.24% of its industry peers.
ALTM's Profit Margin has declined in the last couple of years.
The Operating Margin of ALTM (36.16%) is better than 96.47% of its industry peers.
ALTM's Operating Margin has improved in the last couple of years.
ALTM's Gross Margin of 49.37% is amongst the best of the industry. ALTM outperforms 92.94% of its industry peers.
In the last couple of years the Gross Margin of ALTM has grown nicely.
Industry RankSector Rank
OM 36.16%
PM (TTM) 10.24%
GM 49.37%
OM growth 3Y339.85%
OM growth 5Y12.09%
PM growth 3Y315.53%
PM growth 5Y-4.55%
GM growth 3Y27%
GM growth 5Y9.04%
ALTM Yearly Profit, Operating, Gross MarginsALTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALTM is still creating some value.
Compared to 1 year ago, ALTM has more shares outstanding
The number of shares outstanding for ALTM has been increased compared to 5 years ago.
The debt/assets ratio for ALTM is higher compared to a year ago.
ALTM Yearly Shares OutstandingALTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ALTM Yearly Total Debt VS Total AssetsALTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that ALTM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.29, ALTM is not doing good in the industry: 68.24% of the companies in the same industry are doing better.
ALTM has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALTM (0.11) is better than 83.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC0.4
WACC7.06%
ALTM Yearly LT Debt VS Equity VS FCFALTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ALTM has a Current Ratio of 1.09. This is a normal value and indicates that ALTM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, ALTM is doing worse than 83.53% of the companies in the same industry.
ALTM has a Quick Ratio of 1.09. This is a bad value and indicates that ALTM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALTM (0.56) is worse than 83.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.56
ALTM Yearly Current Assets VS Current LiabilitesALTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALTM have decreased strongly by -94.56% in the last year.
The earnings per share for ALTM have been decreasing by -77.97% on average. This is quite bad
Looking at the last year, ALTM shows a quite strong growth in Revenue. The Revenue has grown by 14.20% in the last year.
The Revenue has been growing by 21.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-94.56%
EPS 3YN/A
EPS 5Y-77.97%
EPS Q2Q%-97.06%
Revenue 1Y (TTM)14.2%
Revenue growth 3Y33.84%
Revenue growth 5Y21.01%
Sales Q2Q%58.97%

3.2 Future

The Earnings Per Share is expected to grow by 53.89% on average over the next years. This is a very strong growth
ALTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.62% yearly.
EPS Next Y11.36%
EPS Next 2Y51.71%
EPS Next 3Y62.79%
EPS Next 5Y53.89%
Revenue Next Year15.71%
Revenue Next 2Y16.95%
Revenue Next 3Y27.33%
Revenue Next 5Y16.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALTM Yearly Revenue VS EstimatesALTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
ALTM Yearly EPS VS EstimatesALTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50 100 150 200 250

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.92, the valuation of ALTM can be described as expensive.
Based on the Price/Earnings ratio, ALTM is valued a bit more expensive than the industry average as 65.88% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.18. ALTM is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 40.34 indicates a quite expensive valuation of ALTM.
Based on the Price/Forward Earnings ratio, ALTM is valued a bit more expensive than the industry average as 68.24% of the companies are valued more cheaply.
ALTM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.34.
Industry RankSector Rank
PE 44.92
Fwd PE 40.34
ALTM Price Earnings VS Forward Price EarningsALTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALTM indicates a slightly more expensive valuation: ALTM is more expensive than 62.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.62
ALTM Per share dataALTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALTM does not grow enough to justify the current Price/Earnings ratio.
ALTM has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALTM's earnings are expected to grow with 62.79% in the coming years.
PEG (NY)3.95
PEG (5Y)N/A
EPS Next 2Y51.71%
EPS Next 3Y62.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Arcadium Lithium plc

NYSE:ALTM (3/5/2025, 8:04:00 PM)

After market: 5.84 0 (0%)

5.84

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners71.08%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change-246.02%
Market Cap6.27B
Analysts70
Price Target6.03 (3.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.28%
Min EPS beat(2)-74.86%
Max EPS beat(2)-3.69%
EPS beat(4)1
Avg EPS beat(4)-11.38%
Min EPS beat(4)-74.86%
Max EPS beat(4)34.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-10.28%
Min Revenue beat(2)-25.87%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)-7.56%
Min Revenue beat(4)-25.87%
Max Revenue beat(4)5.31%
Revenue beat(8)5
Avg Revenue beat(8)295.85%
Revenue beat(12)9
Avg Revenue beat(12)401.08%
Revenue beat(16)13
Avg Revenue beat(16)354.95%
PT rev (1m)0%
PT rev (3m)-3.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)119.38%
EPS NY rev (1m)0%
EPS NY rev (3m)1.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.96%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-5.29%
Valuation
Industry RankSector Rank
PE 44.92
Fwd PE 40.34
P/S 6.22
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1.3
EV/EBITDA 14.62
EPS(TTM)0.13
EY2.23%
EPS(NY)0.14
Fwd EY2.48%
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.94
BVpS5.83
TBVpS4.5
PEG (NY)3.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 1.65%
ROCE 3.88%
ROIC 2.86%
ROICexc 2.89%
ROICexgc 3.41%
OM 36.16%
PM (TTM) 10.24%
GM 49.37%
FCFM N/A
ROA(3y)8.14%
ROA(5y)4.55%
ROE(3y)13.03%
ROE(5y)7.26%
ROIC(3y)8.5%
ROIC(5y)N/A
ROICexc(3y)10.83%
ROICexc(5y)N/A
ROICexgc(3y)11.51%
ROICexgc(5y)N/A
ROCE(3y)11.53%
ROCE(5y)N/A
ROICexcg growth 3Y191.49%
ROICexcg growth 5Y-15.97%
ROICexc growth 3Y175.9%
ROICexc growth 5Y-18.7%
OM growth 3Y339.85%
OM growth 5Y12.09%
PM growth 3Y315.53%
PM growth 5Y-4.55%
GM growth 3Y27%
GM growth 5Y9.04%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr 841.13%
Cap/Sales 103.49%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.56
Altman-Z 1.29
F-Score2
WACC7.06%
ROIC/WACC0.4
Cap/Depr(3y)1054.15%
Cap/Depr(5y)836.79%
Cap/Sales(3y)60.66%
Cap/Sales(5y)51.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.56%
EPS 3YN/A
EPS 5Y-77.97%
EPS Q2Q%-97.06%
EPS Next Y11.36%
EPS Next 2Y51.71%
EPS Next 3Y62.79%
EPS Next 5Y53.89%
Revenue 1Y (TTM)14.2%
Revenue growth 3Y33.84%
Revenue growth 5Y21.01%
Sales Q2Q%58.97%
Revenue Next Year15.71%
Revenue Next 2Y16.95%
Revenue Next 3Y27.33%
Revenue Next 5Y16.62%
EBIT growth 1Y-8.97%
EBIT growth 3Y488.68%
EBIT growth 5Y35.64%
EBIT Next Year99.7%
EBIT Next 3Y72.01%
EBIT Next 5Y51.11%
FCF growth 1Y-3990.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-159.2%
OCF growth 3YN/A
OCF growth 5YN/A